NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 1423

Display Results as:

Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01) - RFA-CA-17-052

Organization: NCI 

Posting Date: 09-25-2017 

Expiration Date: 01-18-2018 

Activity Code: U01 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer Moonshot InitiativeSM that is intended to accelerate cancer research. The purpose of this FOA is to promote research on developing the descriptive, inferential, and graphical statistical methods for data generated in clinical trials including Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) items. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Accelerate research that can identify approaches to monitor and manage patient-reported symptoms.  

Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1) - RFA-CA-17-042

Organization: NCI 

Posting Date: 10-18-2017 

Expiration Date: 01-18-2018 

Activity Code: UM1 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of integrated symptom monitoring and management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship. 

Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24) - RFA-CA-17-043

Organization: NCI 

Posting Date: 10-18-2017 

Expiration Date: 01-18-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of comprehensive symptom management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship. 

NCI Research Specialist (Laboratory-based Scientist) Award (R50) - PAR-18-341

Organization: NCI 

Posting Date: 11-02-2017 

Expiration Date: 01-18-2018 

Activity Code: R50 

Summary: This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists. 

NCI Research Specialist (Core-based Scientist) Award (R50) - PAR-18-342

Organization: NCI 

Posting Date: 11-02-2017 

Expiration Date: 01-18-2018 

Activity Code: R50 

Summary: This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. 

Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54) - RFA-CA-17-032

Organization: NCI 

Posting Date: 10-13-2017 

Expiration Date: 01-19-2018 

Activity Code: U54 

Summary: This funding opportunity announcement (FOA) solicits applications for Minority PDX (minority patient-derived xenografts) Development and Trial Centers (M-PDTCs). The M-PDTCs will join the PDTC Research Network (PDXNet) and be focused upon development and pre-clinical testing of models derived from racial/ethnic minority populations. The PDXNet is a National Cancer Institute (NCI) program established to coordinate collaborative, large-scale model development and pre-clinical testing of targeted therapeutic agents to advance the vision of cancer precision medicine. 

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) - RFA-CA-17-033

Organization: NCI 

Posting Date: 10-13-2017 

Expiration Date: 01-19-2018 

Activity Code: P20 

Summary: This Funding Opportunity Announcement (FOA) invites applications for development of translational research programs that are focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build cancer health disparities research programs. It is the expectation that the research programs developed by the P20 awards should be competitive with other applications for a full Specialized Programs of Research Excellence (SPORE), addressing cancer health disparities as a cross-cutting research theme. 

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) - RFA-CA-17-038

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: UG3/UH3 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. This purpose of this FOA is to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based approaches. 

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24) - RFA-CA-17-039

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research in colorectal cancer screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based Approaches. 

Human Tumor Atlases (HTA) Precancer Atlas Research Centers (U2C) - RFA-CA-17-035

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U2C 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic, multidimensional tumor ecosystem. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases. 

Human Tumor Atlases (HTA) Research Centers (U2C) - RFA-CA-17-034

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U2C 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic multidimensional tumor ecosystem. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases. 

Human Tumor Atlas Network: Data Coordinating Center (U24) - RFA-CA-17-036

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic multidimensional tumor ecosystem. Specifically, this FOA targets the following area(s) designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases. 

Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33) - RFA-AT-18-002

Organization: NCCIH  (formerly NCCAM)

Posting Date: 11-16-2017 

Expiration Date: 01-19-2018 

Activity Code: R21/R33 

Summary: The purpose of this FOA is to solicit applications to examine the impact of behavioral interventions within the context of states plans for use of the SAMHSA Opioid STR grant funds authorized under the 21st Century Cures Act. Applications are encouraged for studies that examine the impact of interventions such as mindfulness meditation, cognitive behavioral therapy, or multi-disciplinary rehabilitation for primary or secondary prevention for opioid use disorder (OUD) or as an adjunct to medication assisted treatment (MAT) of OUD. Applications that emphasize treatment of the comorbidity of OUD and chronic pain are of particular interest. 

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01) - RFA-NS-18-010

Organization: NINDS 

Posting Date: 10-05-2017 

Expiration Date: 01-20-2018 

Activity Code: U01 

Summary: Invasive surgical procedures provide the unique ability to record and stimulate neurons within precisely localized brain structures in humans. Human studies using invasive technology are often constrained by a limited number of patients and resources available to implement complex experimental protocols and are rarely aggregated in a manner that addresses research questions with appropriate statistical power. Therefore, this FOA seeks applications to assemble integrated, multi-disciplinary teams to overcome these fundamental barriers. Projects should investigate high-impact questions in human neuroscience. The research should be offered as exploratory research and planning activities to establish feasibility, proof-of-principle and early-stage development that will later compete for continued funding under new or ongoing FOAs of the BRAIN Initiative or under NIH Institute appropriations. Projects should maximize opportunities to conduct innovative in vivo neuroscience research made available by direct access to brain recording and stimulating from invasive surgical procedures. In addition, projects that aim to implement novel methods of temporally-linked brain-behavior quantification in laboratory and real-world settings are encouraged. Awardees will join a consortium work group, coordinated by the NIH, to identify consensus standards of practice as well as supplemental opportunities to collect and provide data for ancillary studies, and to aggregate and standardize data for dissemination among the wider scientific community. 

Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10) - RFA-CA-17-056

Organization: NCI 

Posting Date: 10-19-2017 

Expiration Date: 01-20-2018 

Activity Code: U10 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain a Network Group Operations Center for the NCI National Clinical Trials Network (NCTN). The NCTN Network Group Operations Centers will provide scientific leadership for developing and implementing multi-disciplinary, multi-institutional trials in a range of cancer types and special populations with specific scientific strategy and goals. 

Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10) - RFA-CA-17-057

Organization: NCI 

Posting Date: 10-19-2017 

Expiration Date: 01-20-2018 

Activity Code: U10 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain Network Group Statistics and Data Management Centers (SDMCs) for the NCI National Clinical Trials Network (NCTN). The NCTN Network SDMCs will provide statistical expertise for effective scientific design, conduct, and data management of clinical trials led by the associated NCTN Network Group Operations Center. 

Limited Competition: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10) - RFA-CA-17-058

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-20-2018 

Activity Code: U10 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain a Canadian Collaborating Clinical Trials Network for the NCI National Clinical Trials Network (NCTN). The NCTN Canadian Collaborating Clinical Trials Network will be a full partner with the U.S. Network in the conduct of large-scale, multi-site clinical trials and help provide regulatory expertise/oversight for the conduct of NCTN trials in Canada. The competition for an award under this FOA is limited to eligible Canadian institutions. 

NCI National Clinical Trials Network (NCTN)--Network Lead Academic Participating Sites (UG1) - RFA-CA-17-059

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-20-2018 

Activity Code: UG1 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain or establish Network Lead Academic Participating Sites (LAPS) for the NCI National Clinical Trials Network (NCTN). The NCTN Network LAPS will provide scientific leadership by helping to develop and conduct clinical trials in association with one or more adult Network Groups and will contribute substantial accrual to clinical trials conducted across the entire NCTN. 

Limited Competition: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24) - RFA-CA-17-060

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-20-2018 

Activity Code: U24 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications to maintain a Network Radiotherapy and Imaging Core Services Center for the NCI National Clinical Trials Network (NCTN) that provides scientific and technical expertise for incorporating integrated quality assurance and image data management for applicable NCTN clinical trials that involve interventions with radiotherapy and/or imaging modalities. In addition, the Center will have the capacity to provide similar services for other approved NCI-supported clinical trials network programs (e.g., the NCI/DCTD early phase clinical trial network program and the NCI/DCP NCI Community Oncology Research Program). 

NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1) - RFA-CA-17-061

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-20-2018 

Activity Code: UG1 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain or establish Network Group Integrated Translational Science Centers for the NCI National Clinical Trials Network (NCTN). The NCTN Network Group Integrated Translational Science Centers will provide support for leadership and expertise to facilitate incorporating translational science into Network Group clinical trials, including the conduct of pilot projects to collect preliminary data. 

Limited Competition: RCMI Research Coordination Network (RRCN) (U54) - RFA-MD-18-001

Organization: NIMHD 

Posting Date: 11-17-2017 

Expiration Date: 01-20-2018 

Activity Code: U54 

Summary: The RCMI Research Coordination Network (RRCN), formerly known as the RCMI Translational Research Network (RTRN), was established in 2007 to enhance collaboration across RCMI institutions. The network is designed to engage all stakeholders in the RCMI institutions, increase the quality and efficiency of basic biomedical, behavioral, and clinical research, facilitate study participant recruitment and retention, and increase the efficiency of the implementation and dissemination of research advances to improved health outcomes among minority and health disparity populations. Maintaining the longstanding networking and collaboration with the RCMI grantee community is key to the continued success of this program. 

NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed) - RFA-MH-18-600

Organization: NIMH 

Posting Date: 11-06-2017 

Expiration Date: 01-23-2018 

Activity Code: R21/R33 

Summary: This Funding Opportunity Announcement (FOA) encourages applications that will develop novel technologies and/or tools for the isolation and characterization of extracellular vesicles (EVs) of Central Nervous System (CNS) origin. The primary focus of the technology development includes robust and reproducible CNS-EV isolation methods. Specifically, there is a need to establish technologies for the isolation and purification of CNS-EVs from peripheral samples and the characterization of CNS-EV types, cargos, and origin, as well as to validate these methods for further analyses. Validation of these technologies may include the analysis of the full range of EV composition such as RNA, proteins, lipids, and metabolites.  

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42) - RFA-HD-18-101

Organization: NICHD 

Posting Date: 11-22-2017 

Expiration Date: 01-23-2018 

Activity Code: R41/R42 

Summary: The purpose of this initiative is to invite STTR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viable and effective combination prevention modality would be ideal and critical for these young women who are at risk for HIV and who desire protection against pregnancy. 

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) - RFA-HD-18-102

Organization: NICHD 

Posting Date: 11-22-2017 

Expiration Date: 01-23-2018 

Activity Code: R43/R44 

Summary: The purpose of this initiative is to invite SBIR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viable and effective combination prevention modality would be ideal and critical for these young women who are at risk for HIV and who desire protection against pregnancy. 

NeuroNEXT Infrastructure Resource Access (X01) - PAR-15-195

Organization: NINDS 

Posting Date: 04-30-2015 

Expiration Date: 01-24-2018 

Activity Code: X01 

Summary: This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol.  

Current Search

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

ORD

ORI

ORIP

ORWH

OSC

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top